Thursday, 27 August 2026

Scientists Identify New Pathway to Combat Liver Inflammation
Drug Doses

Scientists Identify New Pathway to Combat Liver Inflammation

Researchers find hormone GDF15 triggers a brain‑to‑liver pathway that cuts liver inflammation and fibrosis, offering therapy even without weight loss.

By Calloway Fairfax  •  August 22, 2026
Read More



FDA approves first-of-its-kind therapy for metastatic pancreatic cancer
Stress Checks

FDA approves first-of-its-kind therapy for metastatic pancreatic cancer

FDA approves Rasonque, a first-in-class therapy for metastatic pancreatic cancer. Learn about this new targeted treatment.

By Calloway Fairfax  •  27/08/2026
6 Signs You May Benefit from Facial Rejuvenation
Diet Links

6 Signs You May Benefit from Facial Rejuvenation

Most people considering facial rejuvenation describe the same vague feeling: something looks different, but they cannot say exactly…

By Calloway Fairfax  •  27/08/2026
Stem cell donors getting younger and better
Monitor Picks

Stem cell donors getting younger and better

Stem cell donors are getting younger and better, with mismatched unrelated donors showing promising survival rates for adults…

By Calloway Fairfax  •  26/08/2026
Study links early ADHD risk to caregiving approach
BP Trends

Study links early ADHD risk to caregiving approach

A new study reveals how sensitive caregiving in infancy may reduce ADHD risk linked to prenatal inflammation, offering…

By Lyra Ashworth  •  25/08/2026
Anti-inflammatories emerge as new seborrheic dermatitis treatment
BP Trends

Anti-inflammatories emerge as new seborrheic dermatitis treatment

Discover why dermatologists are shifting toward anti-inflammatory seborrheic dermatitis treatment to improve patient outcomes and reduce drug resistance.

By Calloway Fairfax  •  25/08/2026
FDA approves new drug for rare bone disease
Diet Links

FDA approves new drug for rare bone disease

The FDA approves Pasatru, a breakthrough drug for fibrodysplasia ossificans progressiva (FOP), a rare bone disease affecting 900…

By Ember Pennington  •  24/08/2026
Sparsentan Access Guidance for Kidney Disease Patients
Diet Links

Sparsentan Access Guidance for Kidney Disease Patients

Sparsentan access guidance for kidney disease patients with evidence-based coverage criteria and clinical judgment.

By Calloway Fairfax  •  23/08/2026
Scientists Identify New Pathway to Combat Liver Inflammation
Drug Doses

Scientists Identify New Pathway to Combat Liver Inflammation

Researchers find hormone GDF15 triggers a brain‑to‑liver pathway that cuts liver inflammation and fibrosis, offering therapy even without…

By Calloway Fairfax  •  22/08/2026
Clinical Trial Joining: The Hurdles You Need to Know
Monitor Picks

Clinical Trial Joining: The Hurdles You Need to Know

Discover the hurdles of clinical trial joining and how to overcome them with ease and success in medical…

By Ember Pennington  •  19/08/2026
California’s generic insulin struggles to gain traction
Diet Links

California’s generic insulin struggles to gain traction

California’s generic insulin program, CalRx, offers affordable insulin at $55 but faces slow adoption despite lower costs. Learn…

By Lyra Ashworth  •  18/08/2026